The bill enacts a new provision in the Uniform Controlled Dangerous Substances Law, specifically adding Tianeptine to Schedule I. This addition is outlined in the newly inserted section R.S. 40:964(Schedule I)(G), which states that any material, compound, mixture, or preparation containing Tianeptine, including its salts and isomers, is classified under Schedule I unless it is specifically exempted or part of a pharmaceutical product approved by the United States Food and Drug Administration.

This legislative action aims to regulate Tianeptine due to its potential risks and to ensure that it is controlled under the same stringent measures as other substances classified in Schedule I. The bill reflects a proactive approach to public health and safety by addressing the concerns associated with the use of Tianeptine.